Grand Brilliance Group Holdings Ltd is an investment holding company primarily engaged in the supply of medical devices. The Company also provides medical device solutions, including market trend analysis, medical device procurement, after-sales service, technical support and training, medical device rental services, and quality assurance. The Company primarily sells medical device products, including medical consumables, medical equipment, and medical devices. In addition, the Company also offers repair services and medical device rental services.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
29/07/26	HK$0.1250	-2.34%	90,000
28/07/26	HK$0.1280	-0.78%	380,000
27/07/26	HK$0.1290	-3.01%	20,000
24/07/26	HK$0.1330	0.00%	0
23/07/26	HK$0.1330	0.00%	0

Delayed Quote Hong Kong S.E.

More quotes

Income Statement and Estimates

More financial data

Delayed Hong Kong S.E. Other stock markets 05:24:27 29/07/2026 +03			5-day change	1st Jan Change
0.1250 ^HKD	-2.34%		-6.02%	-4.58%

06-26	Grand Brilliance Group Holdings Limited Announces Interim Ordinary Cash Dividend for the Financial Year End 31 March 2026, Payable on August 10, 2026	CI
06-26	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI

Market Cap	102M 13.06M 11.46M 10.67M 9.82M 18.4M 1.25B 18.72M 127M 49.56M 619M 49.03M 47.97M 2.14B	P/E 2025	9.13x	P/E 2026	12.5x
Enterprise Value	47.05M 6M 5.27M 4.9M 4.51M 8.45M 573M 8.6M 58.17M 22.77M 284M 22.53M 22.04M 982M	EV / Sales 2025	0.25x	EV / Sales 2026	0.49x
Free-Float	27.02%	Yield 2025	2.31%	Yield 2026	1.91%

06-26	Grand Brilliance Group Holdings Limited Announces Interim Ordinary Cash Dividend for the Financial Year End 31 March 2026, Payable on August 10, 2026	CI
06-26	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
11-21	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2025	CI
20/06/25	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
20/06/25	Grand Brilliance Group Holdings Limited Announces Interim Dividend for the Financial Year End 31 March 2025, Payable on August 11, 2025	CI
27/05/25	Grand Brilliance Group Holdings Limited Announces Board and Committee Changes, Effective 1 June 2025	CI
14/03/25	Grand Brilliance Group Holdings Limited Announces Resignation of Mr. Mui Wai Sum as Independent Non-Executive Director and Chairman and Member of the Audit Committee and Member of Remuneration Committee	CI
08/11/24	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2024	CI
28/06/24	Grand Brilliance Group Holdings Limited Declares Interim Dividend for the Year Ended 31 March 2024, Payable on or Before 12 August 2024	CI
28/06/24	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
13/11/23	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI
15/09/23	Grand Brilliance Group Holdings Limited Announces Board Changes, Effective September 18, 2023	CI
11/08/23	Grand Brilliance Group Holdings Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	CI

1 day	-2.34%
1 week	-6.02%
Current month	-10.71%
1 month	-5.30%
3 months	-13.79%
6 months	-6.02%
Current year	-4.58%

Grand Brilliance Group Holdings Limited Stock

Stocks

8372

KYG4136R1020

Medical Equipment, Supplies & Distribution

Valuation: Grand Brilliance Group Holdings Limited

Chart: Grand Brilliance Group Holdings Limited

Latest news : Grand Brilliance Group Holdings Limited

Quotes and Performance

Course Extremes

Managers and Directors: Grand Brilliance Group Holdings Limited

Medical Equipment Wholesale

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	0.12	0.13
1 month	0.12	0.14
Current year	0.12	0.18
1 year	0.1	0.18
3 years	0.07	0.18
5 years	0.06	0.18
10 years	0.06	0.57

Manager	Title	Age	Since
Bik Kwan Wong CEO	Chief Executive Officer	57	01/03/2018
Chong Chi Cheung DFI	Director of Finance/CFO	48	-
Wai Man Lau SAM	Sales & Marketing	39	01/02/2015

Director	Title	Age	Since
Bik Kwan Wong CHM	Chairman	57	01/03/2018
Yin Shun Miu BRD	Director/Board Member	59	18/09/2017
Man Wai Chiu BRD	Director/Board Member	57	18/09/2017

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GRAND BRILLIANCE GROUP HOLDINGS LIMITED	-2.34%	-6.02%	+6.84%	+58.23%	13.16M
HENRY SCHEIN, INC.	+1.30%	-0.17%	+21.64%	+7.58%	9.64B
SHIP HEALTHCARE HOLDINGS, INC.	+1.73%	+7.77%	+21.17%	+10.83%	1.41B
SHANGHAI C&D INNOSTIC MEDICAL TECHNOLOGY GROUP CO., LTD.	-0.75%	-5.12%	-	-	1.32B
AS ONE CORPORATION	+1.86%	+4.82%	+8.87%	-8.76%	1.1B
COWEALTH MEDICAL CHINA CO.,LTD.	+0.19%	+6.35%	+43.57%	+24.01%	609M
GKHT MEDICAL TECHNOLOGY CO., LTD.	+1.07%	+0.47%	-25.09%	-52.06%	579M
EXCELSIOR MEDICAL CO., LTD.	+0.14%	-0.98%	-11.61%	-10.33%	412M
NIPPON CARE SUPPLY CO., LTD.	-0.38%	-4.62%	+88.55%	+133.47%	371M
ACCENDRA HEALTH, INC.	+0.93%	-4.97%	-58.70%	-82.35%	247M
Average	+0.38%	-0.18%	+10.58%	+8.96%	1.57B
Weighted average by Cap.	+1.07%	-0.51%	+19.05%	+6.19%

	2025	2026
Net sales	94.45M 12.05M 10.57M 9.84M 9.05M 16.97M 1.15B 17.26M 117M 45.71M 571M 45.22M 44.24M 1.97B	101M 12.84M 11.27M 10.5M 9.65M 18.1M 1.23B 18.41M 125M 48.74M 609M 48.22M 47.18M 2.1B
Net income	9.46M 1.21M 1.06M 986K 907K 1.7M 115M 1.73M 11.7M 4.58M 57.16M 4.53M 4.43M 197M	8.41M 1.07M 942K 877K 806K 1.51M 103M 1.54M 10.4M 4.07M 50.83M 4.03M 3.94M 176M
Net Debt	-62.36M -7.95M -6.98M -6.5M -5.98M -11.21M -760M -11.4M -77.11M -30.18M -377M -29.86M -29.21M -1.3B	-55.35M -7.06M -6.2M -5.77M -5.31M -9.95M -674M -10.12M -68.44M -26.79M -334M -26.5M -25.93M -1.16B